Kamil Ali-Jackson

Insider Reports History

Entity
Individual
Location
C/O Aclaris Therapeutics, Inc., 101 Lindenwood Drive, Suite 400, Malvern, PA
Signature
/s/ Spencer Brown, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kamil Ali-Jackson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aclaris Therapeutics, Inc. Chief Legal Officer Common Stock 160K $168K $1.05 Jan 3, 2022 Direct
RIGEL PHARMACEUTICALS INC Director Common Stock 68.8K $78.4K $1.14 May 25, 2024 Direct
RIGEL PHARMACEUTICALS INC Director Stock Option (Right to Buy) 30K May 25, 2024 Direct
PDS Biotechnology Corp Director Employee Stock Option (Right to Buy) 9K Jun 24, 2024 Direct
Aclaris Therapeutics, Inc. Chief Legal Officer Restricted Stock Units 0 $1.05 Jan 3, 2022 Direct

Insider Reports Filed by Kamil Ali-Jackson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PDSB PDS Biotechnology Corp Jun 24, 2024 1 $0 4 Jun 25, 2024 Director
RIGL RIGEL PHARMACEUTICALS INC May 25, 2024 2 $0 4 May 29, 2024 Director
PDSB PDS Biotechnology Corp Jul 14, 2023 1 $0 4 Jul 17, 2023 Director
RIGL RIGEL PHARMACEUTICALS INC May 26, 2023 2 $0 4 Jul 12, 2023 Director
PDSB PDS Biotechnology Corp Jun 28, 2022 1 $0 4 Jun 29, 2022 Director
RIGL RIGEL PHARMACEUTICALS INC May 20, 2022 2 $0 4 May 23, 2022 Director
ACRS Aclaris Therapeutics, Inc. Jan 3, 2022 8 $0 4 Jan 5, 2022 Chief Legal Officer
RIGL RIGEL PHARMACEUTICALS INC Dec 16, 2021 1 $0 4 Dec 17, 2021 Director
RIGL RIGEL PHARMACEUTICALS INC Dec 16, 2021 0 $0 3 Dec 17, 2021 Director
PDSB PDS Biotechnology Corp Jun 15, 2021 2 $100K 4 Jun 17, 2021 Director
ACRS Aclaris Therapeutics, Inc. Jun 3, 2021 1 -$208K 4 Jun 4, 2021 Chief Legal Officer
ACRS Aclaris Therapeutics, Inc. Jun 1, 2021 8 -$997K 4 Jun 2, 2021 Chief Legal Officer
ACRS Aclaris Therapeutics, Inc. May 6, 2021 8 -$261K 4 May 7, 2021 Chief Legal Officer
ACRS Aclaris Therapeutics, Inc. Mar 11, 2021 1 $0 4 Nov 22, 2021 Chief Legal Officer